LAVA Depreciation And Amortization vs Interest Expense Analysis

LVTX Stock

USD 1.29 0.06 4.44%

LAVA Therapeutics financial indicator trend analysis is infinitely more than just investigating LAVA Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LAVA Therapeutics is a good investment. Please check the relationship between LAVA Therapeutics Depreciation And Amortization and its Interest Expense accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LAVA Therapeutics NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Depreciation And Amortization vs Interest Expense

Depreciation And Amortization vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LAVA Therapeutics Depreciation And Amortization account and Interest Expense. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between LAVA Therapeutics' Depreciation And Amortization and Interest Expense is 0.43. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Interest Expense in the same time period over historical financial statements of LAVA Therapeutics NV, assuming nothing else is changed. The correlation between historical values of LAVA Therapeutics' Depreciation And Amortization and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of LAVA Therapeutics NV are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Depreciation And Amortization i.e., LAVA Therapeutics' Depreciation And Amortization and Interest Expense go up and down completely randomly.

Correlation Coefficient

0.43

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Most indicators from LAVA Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LAVA Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LAVA Therapeutics NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Tax Provision is likely to rise to about 336.9 K in 2025, whereas Selling General Administrative is likely to drop slightly above 9.5 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	82K	232K	266.8K	300.7K
Depreciation And Amortization	504K	1.3M	1.5M	1.5M

Interest Expense Depreciation And Amortization

LAVA Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.88	0.92	0.81	0.96	0.98	0.88	0.57	-0.89	-0.89	0.89	0.94	0.9	0.77	0.94	0.94	1.0	0.79	0.7	0.89	0.76	0.93	0.96	0.87	0.98	0.85
Short Long Term Debt Total	0.88		0.82	0.88	0.77	0.89	0.99	0.45	-0.64	-0.95	0.93	0.72	0.98	0.79	0.89	0.99	0.88	0.84	0.92	0.93	0.84	0.81	0.94	0.93	0.81	0.92
Other Current Liab	0.92	0.82		0.9	0.85	0.84	0.79	0.83	-0.81	-0.82	0.82	0.85	0.86	0.82	0.85	0.88	0.91	0.93	0.72	0.85	0.66	1.0	0.86	0.87	0.88	0.74
Total Current Liabilities	0.81	0.88	0.9		0.63	0.77	0.87	0.76	-0.52	-0.89	0.92	0.59	0.85	0.67	0.83	0.91	0.8	0.98	0.92	0.94	0.85	0.88	0.87	0.97	0.7	0.87
Total Stockholder Equity	0.96	0.77	0.85	0.63		0.94	0.77	0.47	-0.96	-0.77	0.74	0.99	0.82	0.76	0.86	0.83	0.97	0.63	0.51	0.74	0.58	0.87	0.86	0.71	1.0	0.7
Net Tangible Assets	0.98	0.89	0.84	0.77	0.94		0.91	0.45	-0.85	-0.9	0.91	0.89	0.88	0.67	0.94	0.94	0.98	0.72	0.7	0.9	0.81	0.86	0.98	0.87	0.96	0.89
Property Plant And Equipment Net	0.88	0.99	0.79	0.87	0.77	0.91		0.4	-0.62	-0.96	0.96	0.71	0.96	0.71	0.92	0.98	0.88	0.8	0.92	0.95	0.89	0.78	0.96	0.93	0.81	0.95
Current Deferred Revenue	0.57	0.45	0.83	0.76	0.47	0.45	0.4		-0.5	-0.46	0.53	0.5	0.49	0.54	0.47	0.54	0.56	0.84	0.49	0.59	0.4	0.82	0.5	0.65	0.52	0.43
Net Debt	-0.89	-0.64	-0.81	-0.52	-0.96	-0.85	-0.62	-0.5		0.61	-0.6	-0.98	-0.72	-0.75	-0.71	-0.72	-0.89	-0.55	-0.35	-0.6	-0.41	-0.83	-0.74	-0.58	-0.95	-0.54
Retained Earnings	-0.89	-0.95	-0.82	-0.89	-0.77	-0.9	-0.96	-0.46	0.61		-0.96	-0.71	-0.91	-0.66	-0.96	-0.96	-0.89	-0.83	-0.89	-0.96	-0.91	-0.81	-0.96	-0.95	-0.81	-0.95
Accounts Payable	0.89	0.93	0.82	0.92	0.74	0.91	0.96	0.53	-0.6	-0.96		0.67	0.88	0.58	0.93	0.96	0.89	0.85	0.89	1.0	0.97	0.82	0.98	0.99	0.8	0.99
Cash	0.94	0.72	0.85	0.59	0.99	0.89	0.71	0.5	-0.98	-0.71	0.67		0.8	0.8	0.81	0.78	0.94	0.61	0.45	0.67	0.49	0.87	0.8	0.66	0.98	0.62
Non Current Assets Total	0.9	0.98	0.86	0.85	0.82	0.88	0.96	0.49	-0.72	-0.91	0.88	0.8		0.88	0.88	0.97	0.9	0.84	0.87	0.88	0.75	0.85	0.91	0.88	0.85	0.85
Non Currrent Assets Other	0.77	0.79	0.82	0.67	0.76	0.67	0.71	0.54	-0.75	-0.66	0.58	0.8	0.88		0.65	0.77	0.76	0.74	0.63	0.6	0.36	0.81	0.66	0.63	0.76	0.51
Other Assets	0.94	0.89	0.85	0.83	0.86	0.94	0.92	0.47	-0.71	-0.96	0.93	0.81	0.88	0.65		0.93	0.94	0.78	0.79	0.93	0.86	0.85	0.96	0.91	0.9	0.91
Long Term Debt	0.94	0.99	0.88	0.91	0.83	0.94	0.98	0.54	-0.72	-0.96	0.96	0.78	0.97	0.77	0.93		0.93	0.87	0.89	0.96	0.87	0.87	0.98	0.96	0.87	0.94
Cash And Short Term Investments	1.0	0.88	0.91	0.8	0.97	0.98	0.88	0.56	-0.89	-0.89	0.89	0.94	0.9	0.76	0.94	0.93		0.77	0.69	0.89	0.76	0.92	0.96	0.87	0.99	0.85
Net Receivables	0.79	0.84	0.93	0.98	0.63	0.72	0.8	0.84	-0.55	-0.83	0.85	0.61	0.84	0.74	0.78	0.87	0.77		0.88	0.88	0.74	0.91	0.81	0.93	0.69	0.78
Common Stock Shares Outstanding	0.7	0.92	0.72	0.92	0.51	0.7	0.92	0.49	-0.35	-0.89	0.89	0.45	0.87	0.63	0.79	0.89	0.69	0.88		0.9	0.87	0.7	0.83	0.92	0.57	0.88
Non Current Liabilities Total	0.89	0.93	0.85	0.94	0.74	0.9	0.95	0.59	-0.6	-0.96	1.0	0.67	0.88	0.6	0.93	0.96	0.89	0.88	0.9		0.95	0.84	0.97	0.99	0.8	0.98
Capital Lease Obligations	0.76	0.84	0.66	0.85	0.58	0.81	0.89	0.4	-0.41	-0.91	0.97	0.49	0.75	0.36	0.86	0.87	0.76	0.74	0.87	0.95		0.65	0.91	0.93	0.65	0.98
Other Current Assets	0.93	0.81	1.0	0.88	0.87	0.86	0.78	0.82	-0.83	-0.81	0.82	0.87	0.85	0.81	0.85	0.87	0.92	0.91	0.7	0.84	0.65		0.86	0.86	0.9	0.74
Other Stockholder Equity	0.96	0.94	0.86	0.87	0.86	0.98	0.96	0.5	-0.74	-0.96	0.98	0.8	0.91	0.66	0.96	0.98	0.96	0.81	0.83	0.97	0.91	0.86		0.95	0.9	0.96
Total Liab	0.87	0.93	0.87	0.97	0.71	0.87	0.93	0.65	-0.58	-0.95	0.99	0.66	0.88	0.63	0.91	0.96	0.87	0.93	0.92	0.99	0.93	0.86	0.95		0.77	0.96
Net Invested Capital	0.98	0.81	0.88	0.7	1.0	0.96	0.81	0.52	-0.95	-0.81	0.8	0.98	0.85	0.76	0.9	0.87	0.99	0.69	0.57	0.8	0.65	0.9	0.9	0.77		0.76
Property Plant And Equipment Gross	0.85	0.92	0.74	0.87	0.7	0.89	0.95	0.43	-0.54	-0.95	0.99	0.62	0.85	0.51	0.91	0.94	0.85	0.78	0.88	0.98	0.98	0.74	0.96	0.96	0.76

Click cells to compare fundamentals

LAVA Therapeutics Account Relationship Matchups

LAVA Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	25.2M	157.9M	143.4M	101.7M	117.0M	96.1M
Short Long Term Debt Total	5.0M	5.5M	5.5M	6.3M	7.3M	5.3M
Other Current Liab	3.1M	6.9M	12.9M	4.8M	5.5M	6.1M
Total Current Liabilities	8.8M	5.0M	22.0M	14.9M	17.2M	11.5M
Total Stockholder Equity	9.4M	134.2M	86.0M	51.2M	58.9M	63.1M
Property Plant And Equipment Net	1.8M	2.2M	2.1M	2.5M	2.9M	2.1M
Current Deferred Revenue	5.4M	1.7M	35M	4.3M	4.9M	4.7M
Net Debt	(14.4M)	(145.5M)	(94.9M)	(37.9M)	(34.1M)	(35.8M)
Retained Earnings	(44.4M)	(89.3M)	(108.1M)	(148.1M)	(133.3M)	(126.6M)
Accounts Payable	934K	2.6M	4.0M	4.4M	5.1M	2.7M
Cash	19.4M	151.0M	100.3M	44.2M	50.9M	70.9M
Non Current Assets Total	2.8M	3.1M	2.9M	2.8M	3.2M	2.8M
Non Currrent Assets Other	944.2K	902.4K	809K	319K	366.9K	661.0K
Cash And Short Term Investments	19.4M	151.0M	132.9M	95.6M	109.9M	89.4M
Net Receivables	1.5M	734K	3.3M	1.7M	2.0M	1.6M
Common Stock Shares Outstanding	25.4M	19.8M	25.9M	26.7M	30.7M	25.6M
Liabilities And Stockholders Equity	25.2M	157.9M	143.4M	101.7M	117.0M	96.1M
Non Current Liabilities Total	7.0M	18.6M	35.4M	35.6M	40.9M	21.6M
Capital Lease Obligations	389K	581K	810K	1.0M	1.2M	715.2K
Other Current Assets	928K	2.6M	4.4M	1.6M	1.9M	2.1M
Other Stockholder Equity	43.8M	192.3M	194.4M	206.4M	237.4M	144.4M
Total Liab	15.8M	23.7M	57.4M	50.5M	58.1M	33.1M
Net Invested Capital	9.1M	122.7M	90.7M	56.5M	64.9M	62.8M
Property Plant And Equipment Gross	1.2M	2.6M	3.2M	4.2M	4.9M	2.7M
Total Current Assets	22.4M	154.8M	140.5M	98.9M	113.7M	93.3M
Accumulated Other Comprehensive Income	684.8K	1.3M	(4.0M)	(10.9M)	(9.8M)	(9.3M)
Net Working Capital	9M	125.3M	118.6M	84.0M	96.5M	75.3M
Short Term Debt	1.7M	261K	5.0M	5.7M	6.6M	6.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for LAVA Stock Analysis

When running LAVA Therapeutics' price analysis, check to measure LAVA Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LAVA Therapeutics is operating at the current time. Most of LAVA Therapeutics' value examination focuses on studying past and present price action to predict the probability of LAVA Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LAVA Therapeutics' price. Additionally, you may evaluate how the addition of LAVA Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LAVA Depreciation And Amortization vs Interest Expense Analysis

Depreciation And Amortization vs Interest Expense

Depreciation And Amortization vs Interest Expense Correlation Analysis

Correlation Coefficient

Depreciation And Amortization

Interest Expense

LAVA Therapeutics fundamental ratios Correlations

LAVA Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

LAVA Therapeutics fundamental ratios Accounts

Also Currently Popular

Additional Tools for LAVA Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Other Current Liab
Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Liabilities Total	+ 1.0	Accounts Payable
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Long Term Debt	+ 0.99	Short Long Term Debt Total

Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.96	Retained Earnings
Non Current Liabilities Total	- 0.96	Retained Earnings
Long Term Debt	- 0.96	Retained Earnings
Other Assets	- 0.96	Retained Earnings
Accounts Payable	- 0.96	Retained Earnings